Two Sigma Investments
CLOV icon

Two Sigma Investments’s Clover Health Investments CLOV Stock Holding History

Two Sigma Investments’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-504,295
Closed -$1.59M – 3242
2024
Q4 		$1.59M Sell
504,295
-1,134,656
-69% -$4.06M ﹤0.01% 1869
2024
Q3 		$4.62M Buy
1,638,951
+236,603
+17% +$542K 0.01% 1129
2024
Q2 		$1.72M Sell
1,402,348
-1,123,547
-44% -$1.01M ﹤0.01% 1644
2024
Q1 		$2.01M Sell
2,525,895
-1,104,604
-30% -$1.01M ﹤0.01% 1477
2023
Q4 		$3.46M Buy
3,630,499
+1,727,980
+91% +$1.7M 0.01% 1191
2023
Q3 		$2.05M Buy
1,902,519
+1,858,130
+4,186% +$2.21M 0.01% 1373
2023
Q2 		$39.8K Buy
+44,389
New +$39.4K ﹤0.01% 2850
2023
Q1 		– Sell
-225,603
Closed -$210K – 2987
2022
Q4 		$210K Buy
+225,603
New +$301K ﹤0.01% 2377
2022
Q3 		– Sell
-535,215
Closed -$1.15M – 2515
2022
Q2 		$1.15M Sell
535,215
-2,676,894
-83% -$7.11M ﹤0.01% 1483
2022
Q1 		$11.4M Sell
3,212,109
-3,397,519
-51% -$9.85M 0.03% 567
2021
Q4 		$24.6M Buy
+6,609,628
New +$40.5M 0.05% 406

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Two Sigma Investments's CLOV Position: Q1 2025 in Review

Two Sigma Investments sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 504,295 shares — an estimated $1.59M sold.

Two Sigma Investments first reported a position in CLOV in Q4 2021 and held it in 11 quarters. The position peaked at $24.6M in Q4 2021. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

  • Two Sigma Investments reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 504,295 Clover Health Investments shares in Q1 2025, an estimated $1.59M.
  • Two Sigma Investments first reported a position in Clover Health Investments in Q4 2021 and held it in 11 quarters.
  • Two Sigma Investments's Clover Health Investments position peaked at $24.6M in Q4 2021.
  • 202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.